58 Participants Needed

Provider Intervention for HIV Care Outcomes

LD
MG
Overseen ByMarylou Gilbert, JD MA
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: RAND
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Intersectional stigma and medical mistrust are prevalent among Black and Latina/Latino Americans living with HIV and are key contributors to racial/ethnic health disparities; yet, there are no evidence-based provider-level interventions available for HIV care providers to address intersectional stigma and medical mistrust with patients. The investigators propose to develop an online provider intervention, with community stakeholders' input, that provides psychoeducation and skills-building around addressing intersectional stigma and medical mistrust with patients. The investigators will conduct a pilot randomized controlled trial with 60 HIV care physicians (30/condition) to test the acceptability and feasibility of the online intervention and to determine preliminary effects (against a no-intervention control group) on providers' use of skills and HIV care delivery outcomes at baseline, immediate post, and 6-month follow-up.

Research Team

LD

Lu Dong, PhD

Principal Investigator

RAND

Eligibility Criteria

This trial is for clinical providers like doctors, nurses, and physician assistants who treat HIV patients, particularly those from racial/ethnic and sexual minority groups. They must be able to commit time to the study.

Inclusion Criteria

The majority of their patients are from racial/ethnic and sexual minority groups
Clinical providers (including physicians, physician assistants, nurse practitioners, registered nurses/case managers) caring for patients living with HIV
I can commit to the schedule required by the study.

Exclusion Criteria

Not HIV clinical providers
I cannot commit the required time for this trial.

Timeline

Intervention Development

Engaging community stakeholders to develop an online platform for the intervention, including a usability test with 10 HIV clinical care providers.

Not specified

Pilot Randomized Controlled Trial

Conduct a pilot randomized controlled trial with 60 HIV care physicians to test the online provider intervention against a no-intervention control group.

Not specified

Immediate Post-Intervention Evaluation

Mixed-methods process evaluation to determine the acceptability, feasibility, and appropriateness of the intervention.

Immediately after intervention

Follow-up

Participants are monitored for the use of skills and HIV care delivery outcomes at 6-month follow-up.

6 months

Treatment Details

Interventions

  • Provider Intervention on Addressing Intersectional Stigma and Medical Mistrust in Patients with HIV
Trial Overview The trial is testing an online intervention designed to educate healthcare providers on addressing intersectional stigma and medical mistrust in Black and Latina/Latino Americans with HIV. It's a pilot randomized controlled trial comparing this intervention against no intervention.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Provider InterventionExperimental Treatment1 Intervention
The intervention will consist of psychoeducation and skills-building for HIV care providers to gain the knowledge and skills needed to address intersectional stigma and medical mistrust with patients. The intervention will be online and conducted in groups.
Group II: ControlActive Control1 Intervention
No intervention control

Find a Clinic Near You

Who Is Running the Clinical Trial?

RAND

Lead Sponsor

Trials
145
Recruited
617,000+

California Prevention Training Center

Collaborator

Trials
1
Recruited
60+

Brigham and Women's Hospital

Collaborator

Trials
1,694
Recruited
14,790,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security